English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/169233
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


A paradoxical tumor-suppressor role for the Rac1 exchange factor Vav1 in T cell acute lymphoblastic leukemia

AuthorsRobles-Valero, Julio; Lorenzo-Martín, L. Francisco; Fernández-Pisonero, Isabel; Abad, Antonio; Camós, Mireia; Toribio, María Luisa ; Espinosa, Lluis; Bigas, Anna; Bustelo, Xosé R.
Animal models
Gene expression profiling
Rho GTPases
Issue Date2017
CitationCancer Cell 32(5): 608-623.e9 (2017)
AbstractRho guanine exchange factors (GEFs), the enzymes that stimulate Rho GTPases, are deemed as potential therapeutic targets owing to their protumorigenic functions. However, the understanding of the spectrum of their pathobiological roles in tumors is still very limited. We report here that the GEF Vav1 unexpectedly possesses tumor-suppressor functions in immature T cells. This function entails the noncatalytic nucleation of complexes between the ubiquitin ligase Cbl-b and the intracellular domain of Notch1 (ICN1) that favors ICN1 ubiquitinylation and degradation. Ablation of Vav1 promotes ICN1 signaling and the development of T cell acute lymphoblastic leukemia (T-ALL). The downregulation of Vav1 is essential for the pathogenesis of human T-ALL of the TLX clinical subtype, further underscoring the suppressor role of this pathway.
Publisher version (URL)https://doi.org/10.1016/j.ccell.2017.10.004
Identifiersdoi: 10.1016/j.ccell.2017.10.004
e-issn: 1878-3686
issn: 1535-6108
Appears in Collections:(CBM) Artículos
(IBMCC) Artículos
Files in This Item:
File Description SizeFormat 
pardoxleuk.pdf7,46 MBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.